Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 14.23x is 51% above its 5-year average of 9.41x, around the middle of its 5-year range (2.41x–29.00x).
13.97% below its 12-month average of 16.54x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 29.00x.
INTEREST COVERAGE RATIO
14.23x
INTEREST COVERAGE RATIO AVG TTM
16.54x
INTEREST COVERAGE RATIO AVG 3Y
11.44x
INTEREST COVERAGE RATIO AVG 5Y
9.41x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.97%
CURRENT VS 3Y AVG
+24.42%
CURRENT VS 5Y AVG
+51.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
+362.55%
vs the sector median at left
Harmony Biosciences Holdings, Inc.
Market Cap
$2.32B
Interest Coverage Ratio
14.23x
TTM Avg
16.54x
3Y Avg
11.44x
5Y Avg
9.41x
Market Cap
$2.29B
Interest Coverage Ratio
-0.25x
TTM Avg
23.23x
3Y Avg
12.79x
5Y Avg
10.35x
Market Cap
$2.37B
Interest Coverage Ratio
-2.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.38B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.40B
Interest Coverage Ratio
26.93x
TTM Avg
18.45x
3Y Avg
12.59x
5Y Avg
12.59x
Market Cap
$2.41B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Interest Coverage Ratio
-358.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.44B
Interest Coverage Ratio
-78.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.47B
Interest Coverage Ratio
-65.43x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | $2.32B | 14.23x | 16.54x | 11.44x | 9.41x |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | -0.25x | 23.23x | 12.79x | 10.35x |
| Liquidia Corporation (LQDA)vs › | $2.37B | -2.13x | N/A | N/A | N/A |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.38B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.40B | 26.93x | 18.45x | 12.59x | 12.59x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | N/A | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | -358.08x | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.44B | -78.14x | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.47B | -65.43x | N/A | N/A | N/A |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
Interest Coverage
14.2x
Debt/Equity
0.15
Current Ratio
3.48
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 29.00x |
| 2026-03-31 | 11.53x |
| 2025-12-31 | 10.87x |
| 2025-09-30 | 18.09x |
| 2025-06-30 | 13.21x |
| 2025-03-31 | 14.66x |
| 2024-12-31 | 13.24x |
| 2024-09-30 | 14.19x |
| 2024-06-30 | 4.85x |
| 2024-03-31 | 11.47x |
| 2023-12-31 | 8.38x |
| 2023-09-30 | 9.20x |
| 2023-06-30 | 7.54x |
| 2023-03-31 | 7.05x |
| 2022-12-31 | 13.29x |
| 2022-09-30 | 2.41x |
| 2022-06-30 | 7.91x |
| 2022-03-31 | 6.51x |
| 2021-12-31 | 6.74x |
| 2021-09-30 | 3.84x |
| 2021-06-30 | 3.23x |
| 2021-03-31 | 2.04x |
| 2020-12-31 | 0.97x |
| 2020-09-30 | 1.49x |
| 2020-06-30 | 1.05x |
| 2020-03-31 | -1.51x |
| 2019-12-31 | -12.27x |
| 2019-09-30 | -14.23x |
| 2019-06-30 | -14.24x |
